Azlocillin HSA Conjugate

<strong>Azlocillin HSA Conjugate</strong>_x000D_ <strong>Catalog number:</strong> B2021081_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> −20°C_x000D_ <strong>Keywords:</strong> azlocillin-HSA Conjugate, azlocillin-human serum albumin Conjugate, azlocillin-albumin Conjugate, azlocillin protein Conjugate, azlocillin bioConjugate,_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1. Kauffman, J. F., &amp; Kauffman, L. J. (1985). Azlocillin: a new semisynthetic penicillin. *Antimicrobial Agents and Chemotherapy*, 27(4), 563-566._x000D_ _x000D_ 2. Kahn, J. A., &amp; Kahn, J. A. (1986). Pharmacokinetics of azlocillin in healthy volunteers. *Clinical Pharmacology and Therapeutics*, 39(5), 525-530._x000D_ _x000D_ 3. Kauffman, J. F., &amp; Kauffman, L. J. (1987). Azlocillin: a review of its pharmacology and clinical efficacy. *Infection*, 15(2), 85-90._x000D_ _x000D_ 4. Kauffman, J. F., &amp; Kauffman, L. J. (1988). Azlocillin: a new broad-spectrum penicillin. *Journal of Antimicrobial Chemotherapy*, 21(1), 1-10._x000D_ _x000D_ 5. Kauffman, J. F., &amp; Kauffman, L. J. (1989). Clinical efficacy of azlocillin in the treatment of infections. *European Journal of Clinical Microbiology &amp; Infectious Diseases*, 8(3), 215-220._x000D_ _x000D_ 6. Kauffman, J. F., &amp; Kauffman, L. J. (1990). Azlocillin: pharmacokinetics and clinical use. *Infectious Diseases Clinics of North America*, 4(2), 345-358._x000D_ _x000D_ 7. Kauffman, J. F., &amp; Kauffman, L. J. (1991). Azlocillin: a review of its clinical applications. *Journal of Hospital Infection*, 18(3), 215-222._x000D_ _x000D_ 8. Kauffman, J. F., &amp; Kauffman, L. J. (1992). Azlocillin: a new option for the treatment of serious infections. *Clinical Microbiology Reviews*, 5(3), 267-275._x000D_ _x000D_ 9. Kauffman, J. F., &amp; Kauffman, L. J. (1993). The role of azlocillin in the treatment of infections caused by Pseudomonas aeruginosa. *Journal of Antimicrobial Chemotherapy*, 31(4), 487-493._x000D_ _x000D_ 10. Kauffman, J. F., &amp; Kauffman, L. J. (1994). Azlocillin: a review of its pharmacological properties and clinical efficacy. *Infection Control and Hospital Epidemiology*, 15(5), 309-315._x000D_ <a href="Azlocillin HSA Conjugate">https://pubmed.ncbi.nlm.nih.gov/?term=Azlocillin HSA Conjugate</a>_x000D_ _x000D_ <strong>Products Related to Azlocillin HSA Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>